[Federal Register Volume 88, Number 153 (Thursday, August 10, 2023)]
[Notices]
[Pages 54331-54332]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17185]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Integrating Health Disparities into Immuno-Oncology (HDIO).
    Date: September 27, 2023.
    Time: 10:00 a.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W248, Rockville, Maryland 20850 (Virtual 
Meeting).
    Contact Person: Shree Ram Singh, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W248, Rockville, Maryland 20850, 240-672-6175, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-1: NCI Clinical and Translational Cancer Research.
    Date: September 28, 2023.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W108, Rockville, Maryland 20850 (Virtual 
Meeting).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Pancreatic Cancer Detection Consortium U01.
    Date: October 17, 2023.
    Time: 12:30 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W618, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: E. Tian, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W618, Rockville, Maryland 20850, 240-276-6611, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Research Specialist Award (R50) Clinical.
    Date: October 19, 2023.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W242, Rockville, Maryland 20850 (Virtual 
Meeting).
    Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W242, Rockville, Maryland 20850, 240-276-6372, 
[email protected],

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Primary Care Needs of Cancer Survivors (U01).
    Date: October 19, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 54332]]

    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W108, Rockville, Maryland 20850 (Virtual 
Meeting).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-7: NCI Clinical and Translational Cancer Research.
    Date: October 19, 2023.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W640, Rockville, Maryland 20850 (Virtual 
Meeting).
    Contact Person: Saejeong J. Kim, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W640, Rockville, Maryland 20850, 240-276-7684, 
[email protected],

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-10: NCI Clinical and Translational Cancer Research.
    Date: October 24, 2023.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W606, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Bruce Daniel Hissong, Ph.D., Scientific Review 
Officer, Resource and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W606, Rockville, Maryland 20850, 240-276-7752, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Assay Validation of Biomarkers (UH2/UH3).
    Date: October 26, 2023.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W120, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Majed M. Hamawy, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W120, Rockville, Maryland 20850. 240-276-6457, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-2: NCI Clinical and Translational Cancer Research.
    Date: November 2, 2023.
    Time: 10:30 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W242, Rockville, Maryland 20850 (Virtual 
Meeting).
    Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W242, Rockville, Maryland 20850, 240-276-6372, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Metastasis Research Network (U01).
    Date: November 16, 2023.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W624, Rockville, Maryland 20850 (Telephone 
Conference Call)
    Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W624, Rockville, Maryland 20850, 240-276-6132, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 7, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-17185 Filed 8-9-23; 8:45 am]
BILLING CODE 4140-01-P